期刊文献+

HIF-1α、PTEN在多发性骨髓瘤患者骨髓组织中的表达 被引量:3

Expression of HIF-1α and PTEN in human multiple myeloma bone marrow
原文传递
导出
摘要 目的研究多发性骨髓瘤(MM)骨髓组织中缺氧诱导因子1α(HIF—1α)和第10号染色体同源丢失性磷酸酶一张力蛋白基因(PTEN)的表达,探讨HIF-1α、PTEN在MM发病中的作用。方法应用SP免疫组织化学法检测28例初诊MM患者骨髓活检组织塑料包埋切片中HIF—1α和PTEN的蛋白表达。结果初诊MM患者骨髓组织中HIF-1α的阳性表达率为71.4%(20/28),与对照组的16.5%比较,差异有统计学意义(P〈0.01);初诊MM患者骨髓组织中PTEN阳性表达率为42.9%(12/28),与对照组的100%比较,差异有统计学意义(P〈0.01)。初诊MM患者骨髓组织中HIF—1α与PTEN的表达呈中等强度负相关性(rn=-0.542,P〈0.05)。结论抑癌基因PTEN的缺失或表达下调及H1F-1α的过度表达可能在MM的发生、发展、浸润等生物学行为中起重要的作用,有可能作为临床监测MM进展的指标之一。 Objective To investigate HIF-loL and PTEN expression in multiple myeloma (MM). Methods The expression of HIF-1α and PTEN was studied in 28 cases of MM with immunohistochemistry. Results Over-expression of HIF-1α was frequently (20 of 28 cases, 71.4 %) detected in MM bone marrow. Expression of HIF-1α between MM and control group bone marrow has significant differenees(P 〈0.01). The positive expression rate of PTEN in MM bone marrow was 42.9 %(12 of 28 cases). Expression of PTEN between MM and control group bone marrow has significant differences (P 〈0.01). There was negative correlation between the expression of HIF-1α protein and the PTEN protein (P 〈0.05, rn=-0.542). Conclusion The absence or low expression of PTEN and the increased levels of HIF-1α may play a critical role in the formation, development and invasion of MM. HIF-1α and PTEN may be used to estimate the progress of MM.
出处 《白血病.淋巴瘤》 CAS 2009年第9期541-543,共3页 Journal of Leukemia & Lymphoma
基金 安徽省卫生厅临床应用技术项目(20088045)
关键词 多发性骨髓瘤 缺氧诱导因子1 α 亚基 第10号染色体同源丢失性磷酸酶-张力蛋白基因 Multiple Myeloma Hypoxia-indueible factor 1, alpha subunit Phosphatase and tensin homology deleted on chromosome ten
  • 相关文献

参考文献10

  • 1Semenza GL. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med, 2002, 8: s62.
  • 2Kondo K, Klco J, Nakamura E, et al. Inhibition of HIF is necessary for tumor suppression by the yon Hippel-Lindau protein. Cancer Cell, 2002, 1 : 237.
  • 3Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1 α in common human cancers and their metastases. Cancer Res, 1999, 59: 5830-5835.
  • 4Asosingh K, De Raeve H, de Ridder M, et al. Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression. Haematologica, 2005, 90: 810-817.
  • 5曾东风,孔佩艳,陈幸华,张曦,常城,梁雪,高蕾.缺氧诱导因子-1α和PTEN、P53在急性髓性白血病骨髓基质细胞中的表达及意义[J].免疫学杂志,2007,23(3):316-318. 被引量:6
  • 6Li J, Yen C, Liaw D, et al. PTEN,a putative protein tyrosine phospatase gene mutated in human brain,breast,and prostate cancer. Science, 1997, 275: 1943.
  • 7Tsutsui S,Inoue H,Yasuda K,et al. Inactivation of PTEN is associated with a low p27kipl protein expression in breast carcinoma. Cancer, 2005, 104: 2048.
  • 8杨晓军,高鹏,车团结,黄海云.HIF-1α、PTEN和P53在大肠癌中的表达和意义及其相关性的研究[J].中国现代医学杂志,2006,16(9):1326-1330. 被引量:7
  • 9Shi YJ, Gera J, Hu LP, et al. Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CC 1-779. Cancer Res, 2002, 62: 5027-5034.
  • 10Zhong H, Chiles K, Feldser D, et al. Modulation of HIF-1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res, 2000, 60: 1541-1545.

二级参考文献31

  • 1魏海燕,陈立波,王春友.低氧诱导因子-1α mRNA在胰腺癌组织中的表达与胰腺癌生物学特征的关系[J].癌症,2005,24(2):184-188. 被引量:14
  • 2孙旭芳,曾水清,张虹,杨红,程阳,李小青,李贵刚.缺氧条件下视网膜微血管内皮细胞中缺氧诱导因子1和血管内皮生长因子mRNA表达的研究[J].中国现代医学杂志,2005,15(6):825-827. 被引量:5
  • 3SEMENZA GL.HIF-1 Mediator of physiological and pathophysio logical response to hypoxia[J].Appl Physiol,2000,88 (11):1474-1480.
  • 4KONDO K,WILLIAM G,KAELIN JR.The von Hippel-Lindau tumor suppressor gene[J].Experimental Cell Res,2001,264(1):117-125.
  • 5ZHONG H,ANGELO M,LAUGHNER D,et al.Overexpression of hypoxia-inducible factor 1 α in common human cancers and their metastasis[Jl.Cancer Res.1999,59(5):5830-5839.
  • 6HUANG LE,GU J,SCHAU M,et al.Regulation of hypoxia-inducible factor 1 alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway[J].Proc Natl Acad Sci USA,1998,95(14):7987-7992.
  • 7KALLIO PJ,WILSON W J,O'BRIEN S,et al.Regulation of the hypoxia-inducible transcription factor 1 α by the ubiquitin-proteasome pathway[J].Biol Chem,1999,274(4):6519-6525.
  • 8TALKS KL,TURLEY H,GATTER KC,et al.The expression and distribution of the hypoxia inducible factors HIF-1 α and HIF-2 α in normal tissue,cancers and tumor-associated macrophages[J].Am Jpatho,2000,157(2):411-421.
  • 9SUZUKI K,HAYASHI N,MIYAMOTO Y,et al.Expression of vascular permeability/vascular endothelial growth factor in human hepatocellular eaicinoma[J].Cancer Res,1996,56(9):3004.
  • 10SEMENZA GL Targeting HIF-1 for cancer therapy[J].Nat Rev Cancer,2003,3(10):721-732.

共引文献11

同被引文献45

  • 1成志勇,潘崚,牛志云,梁文同,贾志强,颜晓燕,姚丽,杨敬慈.PTEN基因转染对白血病细胞VEGF调控作用的影响[J].肿瘤,2010,30(10):815-821. 被引量:17
  • 2Fang J, Ding M, Yang L, et al. PI3K/PTEN/Akt signaling regulates prostate tumor angiogenesis. Cell Signal, 2007, 19: 2487-2497.
  • 3Jiang BH, Liu LZ. Akt signaling in regulating angiogenesis.Curr Cancer Drug Targets, 2008, 8: 19-26.
  • 4Zhu L, Loo WT, Louis WC. PTEN and VEGF:possible predictors for sentinel lymph node micro-metastasis in breast cancer. Biomed Pharmacother, 2007, 61: 558-561.
  • 5Hamada K, Sasaki T, Koni PA, et al. The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. Genes, 2005, 19: 2054-2065.
  • 6Stambolic V, Tsao MS, Macpherson D, et al. High incidence of breast and endometrial neopiasia resembling human Cowden syndrome in pten+/-mice. Cancer Res, 2000, 60:3605-3611.
  • 7Shen YH, Zhang L, Gan Y, et al. Up-regulation of PTEN mediates p38 MAPK stress signal-induced inhibition of insulin signaling. A cross- talk between stress signaling and insulin signaling in resistin-treated human endothelial ceils. J Biol Chem, 2006, 281: 7727-7736.
  • 8Katso R, Okkenhaug K, Ahmadi K. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis and cancer. Annu Rev Cell Dev Biol, 2001, 17: 615-675.
  • 9Sarbassov DD, Guertin DA, Ali SM, et al. Phosphorylation and regulation of Akt/PKB hy the rictor-mTOR complex. Science, 2005, 307: 1098-1101.
  • 10Ward SG, Finan P. Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents. Curr Opin Pharmacol, 2003, 4: 426- 434.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部